Structural disconnectome mapping of cognitive function in poststroke patients.


Journal

Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837

Informations de publication

Date de publication:
08 2022
Historique:
revised: 19 06 2022
received: 21 02 2022
accepted: 25 06 2022
pubmed: 22 7 2022
medline: 24 8 2022
entrez: 21 7 2022
Statut: ppublish

Résumé

Sequalae following stroke represents a significant challenge in current rehabilitation. The location and size of focal lesions are only moderately predictive of the diverse cognitive outcome after stroke. One explanation building on recent work on brain networks proposes that the cognitive consequences of focal lesions are caused by damages to anatomically distributed brain networks supporting cognition rather than specific lesion locations. To investigate the association between poststroke structural disconnectivity and cognitive performance, we estimated individual level whole-brain disconnectivity probability maps based on lesion maps from 102 stroke patients using normative data from healthy controls. Cognitive performance was assessed in the whole sample using Montreal Cognitive Assessment, and a more comprehensive computerized test protocol was performed on a subset (n = 82). Multivariate analysis using Partial Least Squares on the disconnectome maps revealed that higher disconnectivity in right insular and frontal operculum, superior temporal gyrus and putamen was associated with poorer MoCA performance, indicating that lesions in regions connected with these brain regions are more likely to cause cognitive impairment. Furthermore, our results indicated that disconnectivity within these clusters was associated with poorer performance across multiple cognitive domains. These findings demonstrate that the extent and distribution of structural disconnectivity following stroke are sensitive to cognitive deficits and may provide important clinical information predicting poststroke cognitive sequalae.

Sections du résumé

BACKGROUND AND PURPOSE
Sequalae following stroke represents a significant challenge in current rehabilitation. The location and size of focal lesions are only moderately predictive of the diverse cognitive outcome after stroke. One explanation building on recent work on brain networks proposes that the cognitive consequences of focal lesions are caused by damages to anatomically distributed brain networks supporting cognition rather than specific lesion locations.
METHODS
To investigate the association between poststroke structural disconnectivity and cognitive performance, we estimated individual level whole-brain disconnectivity probability maps based on lesion maps from 102 stroke patients using normative data from healthy controls. Cognitive performance was assessed in the whole sample using Montreal Cognitive Assessment, and a more comprehensive computerized test protocol was performed on a subset (n = 82).
RESULTS
Multivariate analysis using Partial Least Squares on the disconnectome maps revealed that higher disconnectivity in right insular and frontal operculum, superior temporal gyrus and putamen was associated with poorer MoCA performance, indicating that lesions in regions connected with these brain regions are more likely to cause cognitive impairment. Furthermore, our results indicated that disconnectivity within these clusters was associated with poorer performance across multiple cognitive domains.
CONCLUSIONS
These findings demonstrate that the extent and distribution of structural disconnectivity following stroke are sensitive to cognitive deficits and may provide important clinical information predicting poststroke cognitive sequalae.

Identifiants

pubmed: 35861657
doi: 10.1002/brb3.2707
pmc: PMC9392540
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2707

Informations de copyright

© 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC.

Références

Neurology. 2016 Apr 5;86(14):1296-1305
pubmed: 26962070
Heliyon. 2020 Sep 15;6(9):e04854
pubmed: 32995596
Hum Brain Mapp. 2021 Mar;42(4):1167-1181
pubmed: 33216408
Neuroimage. 2005 Apr 1;25(2):607-15
pubmed: 15784440
Med Sci Monit. 2019 Dec 15;25:9585-9593
pubmed: 31838483
Brain. 2020 Jul 1;143(7):2173-2188
pubmed: 32572442
Neuroimage Clin. 2022;35:103099
pubmed: 35772194
Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):E4367-76
pubmed: 27402738
J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):918-926
pubmed: 29666204
J Int Neuropsychol Soc. 2012 Mar;18(2):242-50
pubmed: 22115097
Eur J Neurol. 2014 Sep;21(9):1226-32
pubmed: 24847762
Cell Rep. 2019 Sep 3;28(10):2527-2540.e9
pubmed: 31484066
Stroke. 2014 Oct;45(10):3129-34
pubmed: 25074518
Brain Cogn. 2019 Apr;131:22-33
pubmed: 28865994
Brain Behav. 2022 Aug;12(8):e2707
pubmed: 35861657
J Neurol Sci. 2010 Dec 15;299(1-2):15-8
pubmed: 20889166
Brain. 2021 Aug 17;144(7):2120-2134
pubmed: 33725125
PLoS Comput Biol. 2009 Jun;5(6):e1000408
pubmed: 19521503
J Int Neuropsychol Soc. 2004 Mar;10(2):301-3
pubmed: 15012851
Annu Rev Neurosci. 2011;34:569-99
pubmed: 21692662
Stroke. 2016 Jan;47(1):66-73
pubmed: 26585396
Clin Neurol Neurosurg. 2018 Nov;174:68-74
pubmed: 30216810
Neuroimage Clin. 2021;29:102538
pubmed: 33385880
Nat Commun. 2020 Oct 9;11(1):5094
pubmed: 33037225
J Stroke. 2015 Sep;17(3):256-67
pubmed: 26437992
Med Image Anal. 2001 Jun;5(2):143-56
pubmed: 11516708
N Engl J Med. 2018 Dec 6;379(23):2237-2245
pubmed: 30575457
Neuroimage. 2011 Mar 1;55(1):24-31
pubmed: 21073962
Neuroimage. 2012 Jan 16;59(2):1960-7
pubmed: 21945693
Neuroscience. 2014 Sep 12;276:187-205
pubmed: 24280637
Neuroimage Clin. 2020;25:102159
pubmed: 31927499
Age Ageing. 2013 Jan;42(1):113-6
pubmed: 22923608
Arch Phys Med Rehabil. 1998 Oct;79(10):1255-7
pubmed: 9779680
Stroke. 2019 Oct;50(10):2768-2774
pubmed: 31743084
J Neurophysiol. 2003 Dec;90(6):3750-63
pubmed: 12968011
Stroke. 2019 Oct;50(10):2761-2767
pubmed: 31510905
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
J Neurosci. 2020 Aug 19;40(34):6638-6648
pubmed: 32709694
Cereb Cortex. 2017 Feb 1;27(2):1216-1228
pubmed: 26683170
Neuroimage. 2011 May 15;56(2):455-75
pubmed: 20656037
Front Hum Neurosci. 2021 Jun 10;15:654750
pubmed: 34177491
J Rehabil Med. 2015 Mar;47(3):193-203
pubmed: 25590458
Front Syst Neurosci. 2010 Jul 15;4:
pubmed: 20700385
Neuroscientist. 2014 Apr;20(2):150-9
pubmed: 23835449
Neuroimage. 2004;23 Suppl 1:S250-63
pubmed: 15501095
Neuropsychologia. 2018 Oct;119:464-473
pubmed: 30244003
PLoS One. 2014 Sep 09;9(9):e106768
pubmed: 25203441
Brain Topogr. 2019 Nov;32(6):926-942
pubmed: 31707621
Neuroimage Clin. 2021;30:102635
pubmed: 33799271
J Cogn Neurosci. 2003 Apr 1;15(3):394-408
pubmed: 12729491
Neurology. 2021 Jan 5;:
pubmed: 33402437
Neuroimage. 2011 Feb 1;54(3):2033-44
pubmed: 20851191
Neuroimage Clin. 2015 Jul 17;9:69-74
pubmed: 26413473
Cereb Cortex. 2016 May;26(5):2140-53
pubmed: 25778346
Gigascience. 2018 Mar 1;7(3):1-17
pubmed: 29432527
Eur Stroke J. 2016 Dec;1(4):294-301
pubmed: 31008291
Nat Neurosci. 2013 Sep;16(9):1348-55
pubmed: 23892552
Maturitas. 2009 Nov 20;64(3):165-71
pubmed: 19818568
Brain Struct Funct. 2010 Jun;214(5-6):655-67
pubmed: 20512370
J Neurosci Res. 2022 May;100(5):1171-1181
pubmed: 31498491
Neuroimage. 2012 Mar;60(1):830-46
pubmed: 22178808
Neuroimage. 2009 Jul 1;46(3):786-802
pubmed: 19195496
Nat Rev Neurosci. 2014 Oct;15(10):683-95
pubmed: 25186238
Hum Brain Mapp. 2021 Mar;42(4):1070-1101
pubmed: 33216425
Brain. 2014 Aug;137(Pt 8):2382-95
pubmed: 25057133
Eur J Neurol. 2014 Nov;21(11):1387-93
pubmed: 25040216
Neuroimage. 2014 Oct 1;99:180-90
pubmed: 24862074
Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14247-52
pubmed: 25225403
J Cogn Neurosci. 2018 Feb;30(2):144-159
pubmed: 28984526
Stroke. 2021 Jan;52(1):317-320
pubmed: 33250039
Nat Rev Neurosci. 2019 Jul;20(7):435-446
pubmed: 31127193
J Cereb Blood Flow Metab. 2018 Aug;38(8):1299-1311
pubmed: 28895445
Brain Connect. 2018 May;8(4):245-253
pubmed: 29366339
Neuroimage. 2020 Apr 15;210:116589
pubmed: 32007498
Clin Neuropsychol. 2011 Jan;25(1):119-26
pubmed: 21154110
J Physiol. 2013 Jan 1;591(1):17-31
pubmed: 23090951
Clin Neurophysiol. 2014 Mar;125(3):520-5
pubmed: 24064249
Neurosci Lett. 2007 May 29;419(2):113-8
pubmed: 17485168

Auteurs

Knut K Kolskår (KK)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.
Sunnaas Rehabilitation Hospital HT, Nesodden, Norway.

Kristine M Ulrichsen (KM)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.
Sunnaas Rehabilitation Hospital HT, Nesodden, Norway.

Genevieve Richard (G)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Erlend S Dørum (ES)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.
Sunnaas Rehabilitation Hospital HT, Nesodden, Norway.

Michel Thiebaut de Schotten (MT)

Brain Connectivity and Behaviour Laboratory, Sorbonne Universities, Paris, France.
Groupe d'Imagerie Neurofonctionnelle, Institut des Maladies Neurodégénératives-UMR 5293, CNRS, CEA University of Bordeaux, Bordeaux, France.

Jaroslav Rokicki (J)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.
Centre of Research and Education in Forensic Psychiatry, Oslo University Hospital, Oslo, Norway.

Jennifer Monereo-Sánchez (J)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.
Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, the Netherlands.

Andreas Engvig (A)

Department of Nephrology, Oslo University Hospital, Ullevål, Norway.
Department of Medicine, Diakonhjemmet Hospital, Oslo, Norway.

Hege Ihle Hansen (HI)

Department of Neurology, Oslo University Hospital, Oslo, Norway.

Jan Egil Nordvik (JE)

CatoSenteret Rehabilitation Center, Son, Norway.
Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.

Lars T Westlye (LT)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.
KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway.

Dag Alnaes (D)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Bjørknes College, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH